Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
NCT01901666
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myelogenous Leukemia
Short Stature
Interventions
DRUG:
Growth Hormone
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh